mRNA expression of chemokine receptors on peripheral blood mononuclear cells and correlation with clinical features in systemic lupus erythematosus patients

Chinese Medical Sciences Journal

Volumn 25, Issue 3, 2010, Pages 162-168

  Li, Yu Mei ^a   Chen, Zhi Qiang ^b   Yao, Xu ^b   Yang, Ai Zhen ^c   Li, An Sheng ^b   Liu, Dong Ming ^a   Gong, Juan Qin ^b  

^a JIANGSU UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Central Lab of People's Liberation Army Cancer Center   (China)

Author keywords

Chemokine receptors; Peripheral blood mononuclear cell; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 77958192616     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(10)60042-9     Document Type: Article

References (24)

1. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 5th ed. Baltimore (Maryland): Williams & Wilkins; 1997 .p.627-33.
2. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Ann Rev Immunol 2000; 18:217-42.
3. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7. (Pubitemid 30398626)
4. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:92-7.
5. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Ann Rev Immunol 2000; 18:593-620. (Pubitemid 30365392)
6. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001; 2:102-7.
7. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2:108-15.
8. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001; 2:95-101.
9. Stasikowska O, Danilewicz M, Wagrowska-Danilewicz M. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy. Pol J Pathol 2007; 58:35-40. (Pubitemid 46772996)
10. Wenzel J, Proelss J, Wiechert A, et al. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J Am Acad Dermatol 2007; 56:648-50. (Pubitemid 46400173)
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
12. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35:630-40.
13. Nagase H, Miyamasu M, Yamaguchi M, et al. Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J Immunol 2000; 164:5935-43.
14. Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 2002; 168:6244-52.
15. Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 2006; 3:2274-84. (Pubitemid 46026445)
16. Odegard JM, DiPlacido LD, Greenwald L, et al. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus. J Immunol 2009; 182:4076-84.
17. Enghard P, Humrich JY, Rudolph B, et al. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009; 60:199-206.
18. Al-Saleh J, el-Eissawy S. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity. Egypt J Immunol 2006; 13:41-8.
19. Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11:152-76. (Pubitemid 30020438)
20. Kikuchi T, Andarini S, Xin H, et al. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against legionella pneumophila. Infect Immun 2005; 73:5350-7. (Pubitemid 41192968)
21. Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107:1173-81. (Pubitemid 32422914)
22. Huang H, Li F, Cairns CM, et al. Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem Biophys Res Commun 2001; 281:378-82. (Pubitemid 32928166)
23. Yao X, Chen ZQ, Li YM, et al. Correlation between some Th1 and Th2 cytokine receptor gene polymorphisms and systemic lupus erythematosus in Chinese patients. Int J Dermatol 2007; 46:1129-35.
24. Mamtani M, Rovin B, Brey R, et al. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 2008; 67:1076-83.